205 related articles for article (PubMed ID: 22218923)
21. Scientometric analysis of chemotherapy of canine leishmaniasis (2000-2020).
Olías-Molero AI; Fontán-Matilla E; Cuquerella M; Alunda JM
Parasit Vectors; 2021 Jan; 14(1):36. PubMed ID: 33422141
[TBL] [Abstract][Full Text] [Related]
22. Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol.
Manna L; Reale S; Picillo E; Vitale F; Gravino AE
Cytokine; 2008 Nov; 44(2):288-92. PubMed ID: 18842424
[TBL] [Abstract][Full Text] [Related]
23. Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
Gómez Pérez V; García-Hernandez R; Corpas-López V; Tomás AM; Martín-Sanchez J; Castanys S; Gamarro F
Int J Parasitol Drugs Drug Resist; 2016 Aug; 6(2):133-9. PubMed ID: 27317865
[TBL] [Abstract][Full Text] [Related]
24. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
25. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
Daza González MA; Fragío Arnold C; Fermín Rodríguez M; Checa R; Montoya A; Portero Fuentes M; Rupérez Noguer C; Martínez Subiela S; Cerón JJ; Miró G
Vet J; 2019 Mar; 245():22-28. PubMed ID: 30819422
[TBL] [Abstract][Full Text] [Related]
26. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL
Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619
[TBL] [Abstract][Full Text] [Related]
27. A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis.
Carnielli JBT; Crouch K; Forrester S; Silva VC; Carvalho SFG; Damasceno JD; Brown E; Dickens NJ; Costa DL; Costa CHN; Dietze R; Jeffares DC; Mottram JC
EBioMedicine; 2018 Oct; 36():83-91. PubMed ID: 30268832
[TBL] [Abstract][Full Text] [Related]
28. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum.
Gonçalves G; Campos MP; Gonçalves AS; Figueiredo FB
Rev Bras Parasitol Vet; 2024; 33(1):e015023. PubMed ID: 38359300
[TBL] [Abstract][Full Text] [Related]
30. Miltefosine-resistant Leishmania infantum strains with an impaired MT/ROS3 transporter complex retain amphotericin B susceptibility.
Mondelaers A; Hendrickx S; Van Bockstal L; Maes L; Caljon G
J Antimicrob Chemother; 2018 Feb; 73(2):392-394. PubMed ID: 29165590
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Leishmania infantum infection in equine populations in a canine visceral leishmaniosis transmission area.
Escobar TA; Dowich G; Dos Santos TP; Zuravski L; Duarte CA; Lübeck I; Manfredini V
BMC Vet Res; 2019 Oct; 15(1):381. PubMed ID: 31666069
[TBL] [Abstract][Full Text] [Related]
32. Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum.
Hendrickx S; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
Parasitol Res; 2015 Jul; 114(7):2561-5. PubMed ID: 25877390
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
[TBL] [Abstract][Full Text] [Related]
34. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
[TBL] [Abstract][Full Text] [Related]
35. First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.
Hernández L; Gálvez R; Montoya A; Checa R; Bello A; Bosschaerts T; Jansen H; Rupérez C; Fortin A; Miró G
Parasitol Res; 2014 Jan; 113(1):157-64. PubMed ID: 24192865
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum.
Rosypal AC; Hall JE; Bakunova S; Patrick DA; Bakunov S; Stephens CE; Kumar A; Boykin DW; Tidwell RR
Vet Parasitol; 2007 Apr; 145(3-4):207-16. PubMed ID: 17298866
[TBL] [Abstract][Full Text] [Related]
37. Antileishmanial activity of antiretroviral drugs combined with miltefosine.
Costa S; Machado M; Cavadas C; do Céu Sousa M
Parasitol Res; 2016 Oct; 115(10):3881-7. PubMed ID: 27249967
[TBL] [Abstract][Full Text] [Related]
38. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
[TBL] [Abstract][Full Text] [Related]
40. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas.
Saridomichelakis MN; Mylonakis ME; Leontides LS; Billinis C; Koutinas AF; Galatos AD; Gouletsou P; Diakou A; Kontos VI
Vet Parasitol; 2005 Jun; 130(3-4):199-205. PubMed ID: 15905034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
